340B ESP’s Terms Of Use Set The Tone For The Spurious Demands It Places On Covered Entities.
As we noted in a previous post, 340B ESP is nothing less than a brazen and (in our opinion) unlawful ploy by the drug manufacturers
As we noted in a previous post, 340B ESP is nothing less than a brazen and (in our opinion) unlawful ploy by the drug manufacturers
YOU HANDLE THE MISSION. WE’LL HANDLE THE REST. We understand: Retail pharmacy management is not the job of a Hospital Pharmacy Executive. Patient Care is. When
According to its website, “340B ESP allows 340B covered entities and pharmaceutical manufacturers to work collaboratively to resolve duplicate discounts.” In truth, the quote-unquote “service”
Statistics indicate that up to 70% of all preventable outpatient readmissions are due to prescription non-compliance. Which is why retail pharmacies that effectively improve outpatient
It’s no secret that when pharmacies effectively improve outpatient medication compliance, post-discharge, the impact on outcomes can be profound. Moreover, by significantly reducing readmissions, pharmacies
It’s no secret that Medicare, and private payers, closely monitor health care providers’ readmission rates. If Medicare determines a given health care system has too
ProxsysRx’s Meds To Beds program is so much more than a tangible sign of your system’s care of, and for, the individuals & families you
In our last post , we outlined the six categories of hospitals considered eligible for 340B participation, and introduced the broad eligibility requirements. This week,
340B-eligibility can mean potentially millions of dollars in retail and specialty prescription reimbursements annually. Below are a few of the program’s key requirements. Covered Entities
ProxsysRx optimizes hospitals’ 340B savings & revenue, while keeping them in complete compliance. If your hospital is 340B-eligible, you may be missing-out on millions of